4:16cv6557 • November 11, 2016
Class Period Start
February 19, 2014
Class Period End
November 4, 2016
PSLRA Deadline
January 9, 2017
Case Allegations
10b5
Statutes of Repose
Feb 19, 2017
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
March 21, 2022
Settlement Fund
$33,000,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock or 2% Convertible Senior Notes of Impax Laboratories, Inc. (now known as Impax Laboratories, LLC) (“Impax” or the “Company”) from February 20, 2014 through August 9, 2016, inclusive.
Claim Administrator
JND Legal Administration
Impax Securities Settlement
c/o JND Legal Administration
PO Box 91417 Seattle, WA 98111
+1 833-823-0051
[email protected]
Settlement Website
https://www.impaxsecuritiessettlement.com/Hearing Date
March 31, 2022
Opt-out Deadline
March 4, 2022
Settlement Note
Download hereProof Of Claim
Download here
Jul 15, 2022
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Dec 20, 2021
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Nov 22, 2021
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Aug 12, 2021
Jul 30, 2021
Apr 22, 2021
Apr 19, 2021
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jan 11, 2021
Sep 5, 2019
Aug 12, 2019
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Dec 6, 2018
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Oct 26, 2018
A new complaint has been filed on behalf of certain investors in IMPAX LABORATORIES INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Apr 17, 2017
A new complaint has been filed on behalf of certain investors in IMPAX LABORATORIES INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Feb 15, 2017
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Nov 11, 2016
A securities fraud class action complaint has been filed on behalf of certain investors in IMPAX LABORATORIES INC.
TOP
